Ali Saad Al-Shammari

MD from 🇮🇶 internist to be

[HAIDER AL TAII @HaiderTaii]

Very proud of my wife, Dr. Halah, a rising star in CT surgery, for her publication in Journal of Thoracic and Cardiovascular Surgery @AATSJournals. Excellent work by our research team lead by superstar Dr @allawy98

[Ali Saad Al-Shammari @allawy98]

@HaiderTaii @HalahAbdulameer

[Ali Saad Al-Shammari @allawy98]

My research is available on @ResearchGate: https://t.co/AmzIPz1HLb

[HAIDER AL TAII @HaiderTaii]

Right technique and not higher pressure to achieve VOM occlusion.

#ablateAfib #VOM #Ethanolablation

[Ali Saad Al-Shammari @allawy98]

@JCVPOnline thank you

[mohamed wagdy @mohamed71290435]

Read my lovely new paper

https://t.co/8VVPiaREY0

[Journal of Cardiovascular Pharmacology @JCVPOnline]

Can lowering heart rate after heart transplantation improve long-term graft remodeling, even if survival remains unchanged?
A new systematic review & meta-analysis of 852 heart transplant recipients found that ivabradine significantly reduced heart rate and was associated with lower left ventricular mass index, while showing no significant differences in mortality, graft rejection, ejection fraction, or blood pressure compared with standard care. These findings support ivabradine as a well-tolerated option, particularly for patients who cannot tolerate β-blockers. How do you see ivabradine fitting into post-transplant management? Share your perspective below.
#HeartTransplant #Ivabradine #HeartFailure #CardiovascularResearch #CardioTwitter

https://t.co/eYTrxu0sX8
@allawy98
@Khadali_
@Yousifkurmasha
@shweliya

[Ali Saad Al-Shammari @allawy98]

@JCVPOnline Thank you so much!

[Ali Saad Al-Shammari @allawy98]

@m_rafiqul25 Yesss!

[Ali Saad Al-Shammari @allawy98]

@MT_abuelazm

[Ali Saad Al-Shammari @allawy98]

My most comprehensive analysis to date, mentored by @utmbcardiology, on pharmacologic prevention of heart failure during breast cancer chemotherapy, has been published in the Cardio-Oncology journal. https://t.co/8cIrBl6gZK @ICOSociety @A_Ibrahim_29 @m_rafiqul25 @HaiderTaii

[Ali Saad Al-Shammari @allawy98]

My most comprehensive analysis to date, mentored by @utmbcardiology, on pharmacologic prevention of heart failure during breast cancer chemotherapy, has been published in the Cardio-Oncology journal. https://t.co/8cIrBl6gZK @ICOSociety @A_Ibrahim_29 @m_rafiqul25 @HaiderTaii

[Ali Saad Al-Shammari @allawy98]

Link from here:
https://t.co/C5FTkyxB2n

[Ali Saad Al-Shammari @allawy98]

Pleased to share our new @JICE_EP meta-analysis on AF ablation in elderly patients.
Elderly patients had higher AF recurrence and adverse outcomes, highlighting the need for individualized care.
Grateful to all mentors and co-authors @HaiderTaii @DrMarwanRefaat @AhmedAminMD

[Ali Saad Al-Shammari @allawy98]

@RameshDaggubati @samin_sharma @MyJSCAI

[Ali Saad Al-Shammari @allawy98]

Thank you, JSCAI, for publishing our paper! @RameshDaggubati @samin_sharma
https://t.co/mtbLzqIYSO

[Ali Saad Al-Shammari @allawy98]

Premature Ventricular Complex–induced Full Pre-excitation in Wolff–Parkinson–White Syndrome: A Case Report https://t.co/uj4NX5V1yV

[Ali Saad Al-Shammari @allawy98]

Letter from the Editor in Chief - Dr. DEVI NAIR, MD, FACC, FHRS discussing our paper Al-Shammari et al. - February 2026 https://t.co/kDPwOu6apc

[HAIDER AL TAII @HaiderTaii]

#ablateVT outcomes show a signal toward lower inpatient mortality. @JCardioEP #Epeeps.

[Ali Saad Al-Shammari @allawy98]

@HaiderTaii @JCardioEP Strong work!

[Ali Saad Al-Shammari @allawy98]

Strong work!! Thank you, prestigious @JCardioEP, for publishing our paper:
https://t.co/RXhL3ThQlZ
@ankursingla98 @HaiderTaii